Edenred

Edenred's share rose about 14.5% to €23.68 after the company confirmed it had been contacted by investment funds about possible takeover approaches. According to reports, BC Partners is considering forming a consortium and is said to have approached, among others, PSP Investments. The rally followed because the stock had recently been significantly undervalued and company-specific M&A speculation drove the price, while the broader market provided little support. » Plus sur de.investing.com

Edenred reported Q1 2026 revenue of €730m (+3.1% like-for-like) and intrinsic growth of 8.2% after regulatory effects in Italy and Brazil weighed on reported growth by 5.1 percentage points. Operating revenue was €673m; Mobility grew like-for-like by 10.0% and Benefits & Engagement delivered 7.8% intrinsic growth. The company reconfirms an intrinsic EBITDA outlook of +8% to +12% through 2028, but expects a reported EBITDA decline of 8%–12% for 2026 due to the regulatory effects. Edenred highlights strategic initiatives (Amplify25-28), partnerships such as with EnBW, and increased AI investments to raise productivity. » Plus sur de.investing.com

Edenred delivered record figures in 2025: EBITDA rose to €1,360m (+11.2% like‑for‑like), free cash flow increased to €1,111m with a conversion rate of 82%, and adjusted earnings per share climbed 10% to €2.59. The company pushed ahead with debt reduction (net debt down 31% to €1,241m, leverage 0.9x) and returned €463m to shareholders, while investing heavily in data, AI and growth initiatives. For 2026 management expects short‑term headwinds from a Brazilian decree that could reduce reported EBITDA by 8–12%, views the year as a reset and anticipates sustainable growth from 2027. » Plus sur de.investing.com